dCeMM3?

CAS No. 311787-85-6

dCeMM3?( 2-(1H-benzimidazol-2-ylsulfanyl)-N-(5-chloropyridin-2-yl)acetamide )

Catalog No. M28887 CAS No. 311787-85-6

2-(1H-benzimidazol-2-ylsulfanyl)-N-(5-chloropyridin-2-yl)acetamide is compound used for high-throughput Screening assay.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 49 In Stock
5MG 45 In Stock
10MG 76 In Stock
25MG 155 In Stock
50MG 245 In Stock
100MG 398 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    dCeMM3?
  • Note
    Research use only, not for human use.
  • Brief Description
    2-(1H-benzimidazol-2-ylsulfanyl)-N-(5-chloropyridin-2-yl)acetamide is compound used for high-throughput Screening assay.
  • Description
    2-(1H-benzimidazol-2-ylsulfanyl)-N-(5-chloropyridin-2-yl)acetamide is compound used for high-throughput Screening assay.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    2-(1H-benzimidazol-2-ylsulfanyl)-N-(5-chloropyridin-2-yl)acetamide
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    KRAS G12C
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    311787-85-6
  • Formula Weight
    318.78
  • Molecular Formula
    C14H11ClN4OS
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (156.85 mM)
  • SMILES
    ClC1=CC=C(NC(=O)CSC2=NC3=CC=CC=C3N2)N=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Wang, Lisha, et al. Cbp/ep300 inhibitor and use thereof. Patent WO2021213521A1.
molnova catalog
related products
  • α-Conotoxin RgIA

    α-Conotoxin RgIA (α-RgIA) is a specific α9α10 nAChR antagonist. α-Conotoxin RgIA can be obtained from Conus regius venom. α-Conotoxin RgIA can be used in the study of neurological diseases.

  • ACT-389949

    ACT-389949 is a potent and selective agonist of formyl peptide receptor type 2 (FPR2)/Lipoxin A4 receptor (ALX), with an EC50 of 3 nM for FPR2/ALX internalization into monocytes.

  • (D-Pro4,D-Trp7·9·10)...

    [D-Pro4,D-Trp7,9,10] Substance P (4-11) is a potent tachykinin antagonist.